Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04262375
What this trial is testing

Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

Who this might be right for
Non Small Cell Lung CancerRenal Cell Carcinoma
University Health Network, Toronto
Not applicableNot Yet RecruitingNCT07351266
What this trial is testing

Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00403169
What this trial is testing

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
The Cleveland Clinic 28
Large-scale testing (Phase 3)Study completedNCT00586105
What this trial is testing

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
Bayer 39
Testing effectiveness (Phase 2)WithdrawnNCT07011849
What this trial is testing

Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases

Who this might be right for
Renal Cell CarcinomaBrain Metastasis
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01712685
What this trial is testing

Imaging Studies of Kidney Cancer Using 18F-VM4-037

Who this might be right for
Carcinoma, Renal CellKidney Neoplasms
National Cancer Institute (NCI) 12
Not applicableUnknownNCT02849535
What this trial is testing

Impact of the PRISM-care Multidisciplinary Oncology Program on Secured Drug Intake of Patients With Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Hospices Civils de Lyon 190
Large-scale testing (Phase 3)Study completedNCT02684006
What this trial is testing

Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

Who this might be right for
Renal Cell Cancer
Pfizer 886
Early research (Phase 1)Active Not RecruitingNCT02974738
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

Who this might be right for
Advanced Solid TumorsSolid TumorSolid Carcinoma+13 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 120
Testing effectiveness (Phase 2)Study completedNCT00496587
What this trial is testing

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT05024214
What this trial is testing

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Who this might be right for
Solid TumorsNon-small Cell Lung CancerRenal Cell Carcinoma+1 more
3D Medicines (Sichuan) Co., Ltd. 170
Not applicableUnknownNCT05785052
What this trial is testing

Biomarkers of Renal Cancer

Who this might be right for
Renal Cell CarcinomaTumor, SolidOncocytoma+1 more
Biorek S.R.L. 1,000
Post-approval studies (Phase 4)Study completedNCT01521715
What this trial is testing

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced and/or Metastatic Renal Cell CarcinomaCarcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
iOMEDICO AG 44
Not applicableStudy completedNCT02075658
What this trial is testing

A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation

Who this might be right for
Renal Cell Carcinoma
University of California, Irvine 60
Early research (Phase 1)Study completedNCT00629200
What this trial is testing

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

Who this might be right for
Advanced CancerSolid Tumors
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT00330564
What this trial is testing

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Who this might be right for
Von Hippel-Lindau SyndromeRenal Cell CarcinomaHemangioblastoma
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT03598816
What this trial is testing

PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine
Early research (Phase 1)Ended earlyNCT00520533
What this trial is testing

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Ludwig Institute for Cancer Research 8
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Not applicableStudy completedNCT04637204
What this trial is testing

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Who this might be right for
Renal Cell Carcinoma
Ipsen 1,540
Next Page